Salesforce stock slides as it eyes $2 billion Listen Labs AI acquisition

CRM had a rough week before steadying on Thursday. The stock fell roughly 4% on Tuesday as OpenAI's GPT-6 Astra launch reignited investor fears that general-purpose AI could erode demand for specialized enterprise software, a selloff that also hit ServiceNow (down about 5%) and Intuit (down roughly 4%), with the S&P 500 software and services index off about 1.4% that day. A day later, on Wednesday, Salesforce shares fell a further roughly 2% on reports that the company is in talks to acquire AI research firm Listen Labs for around $2 billion. By Thursday the stock had largely stabilized, trading close to flat.

Listen Labs is an AI-powered customer research platform, and the price under discussion looks rich against its business: the startup generates approximately $30 million in annualized revenue, which puts the reported $2 billion price at roughly a 67x revenue multiple. Listen Labs had reportedly walked away from a signed $125 million Series C term sheet that valued it at $1.5 billion, only months before the Salesforce talks emerged. Talks remain preliminary and could still collapse without a deal.

The Wednesday dip coincided with continued investor focus on Salesforce's Agentforce platform, which the company has been promoting as its core AI monetization story, including at a recent Goldman Sachs investor conference. That framing is separate from the GPT-6 Astra selloff two days earlier: the two moves had different causes and landed on different trading days, even though both fed into a rough week for the stock.

Wall Street's underlying view on Salesforce has stayed constructive through the volatility. The average analyst price target sits at $273.37, implying about 12% upside from current levels, with a Buy-leaning distribution of 39 buy, 15 hold and 2 sell ratings among 56 analysts covering the stock. If the Listen Labs deal closes, Salesforce could fold the startup's AI research technology into its broader AI stack alongside Agentforce and Einstein, though investors will likely want more clarity on financing terms and integration risk before treating it as a clear positive. The deal, and any effect on guidance, remains something to watch rather than a settled outcome.